S. Buell Jennifer's most recent trade in MiNK Therapeutics Inc was a trade of 50,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| MiNK Therapeutics Inc | Jennifer S. Buell | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| MiNK Therapeutics Inc | Jennifer S. Buell | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 11.12 per share. | 02 Jan 2026 | 31,474 | 67,966 | - | 11.1 | 349,991 | Common Stock |
| MiNK Therapeutics Inc | Jennifer S. Buell | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.12 per share. | 02 Jan 2026 | 10,024 | 57,942 | - | 11.1 | 111,467 | Common Stock |
| MiNK Therapeutics Inc | Jennifer S. Buell | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2025 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| MiNK Therapeutics Inc | Jennifer S. Buell | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 15.36 per share. | 09 Sep 2025 | 18,229 | 41,913 | - | 15.4 | 279,997 | Common Stock |
| MiNK Therapeutics Inc | Jennifer S. Buell | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.36 per share. | 09 Sep 2025 | 5,351 | 36,492 | - | 15.4 | 82,191 | Common Stock |
| Agenus Inc | Jennifer S. Buell | Director | Grant, award, or other acquisition of securities at price $ 3.11 per share. | 02 May 2025 | 581 | 19,738 (0%) | 0% | 3.1 | 1,807 | Common Stock |
| Agenus Inc | Jennifer S. Buell | Director | Grant, award, or other acquisition of securities at price $ 2.08 per share. | 18 Apr 2025 | 869 | 19,157 (0%) | 0% | 2.1 | 1,808 | Common Stock |
| Agenus Inc | Jennifer S. Buell | Director | Grant, award, or other acquisition of securities at price $ 1.56 per share. | 04 Apr 2025 | 1,159 | 18,288 (0%) | 0% | 1.6 | 1,808 | Common Stock |
| Agenus Inc | Jennifer S. Buell | Director | Grant, award, or other acquisition of securities at price $ 1.61 per share. | 21 Mar 2025 | 1,123 | 17,129 (0%) | 0% | 1.6 | 1,808 | Common Stock |
| Agenus Inc | Jennifer S. Buell | Director | Grant, award, or other acquisition of securities at price $ 2.35 per share. | 07 Mar 2025 | 409 | 15,646 (0%) | 0% | 2.3 | 961 | Common Stock |
| Agenus Inc | Jennifer S. Buell | Director | Grant, award, or other acquisition of securities at price $ 3.32 per share. | 21 Feb 2025 | 626 | 15,318 (0%) | 0% | 3.3 | 2,078 | Common Stock |
| Agenus Inc | Jennifer S. Buell | Director | Grant, award, or other acquisition of securities at price $ 3.32 per share. | 21 Feb 2025 | 545 | 15,237 (0%) | 0% | 3.3 | 1,809 | Common Stock |
| Agenus Inc | Jennifer S. Buell | Director | Grant, award, or other acquisition of securities at price $ 3.50 per share. | 07 Feb 2025 | 516 | 14,692 (0%) | 0% | 3.5 | 1,806 | Common Stock |
| Agenus Inc | Jennifer S. Buell | Director | Grant, award, or other acquisition of securities at price $ 3.57 per share. | 24 Jan 2025 | 776 | 14,446 (0%) | 0% | 3.6 | 2,770 | Common Stock |
| Agenus Inc | Jennifer S. Buell | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.57 per share. | 24 Jan 2025 | 270 | 14,176 (0%) | 0% | 3.6 | 964 | Common Stock |
| Agenus Inc | Jennifer S. Buell | Director, Chairman Executive Council | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2024 | 300,000 | 300,000 | - | - | Stock Option | |
| MiNK Therapeutics Inc | S. Buell Jennifer | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 660,919 | 660,919 | - | - | Stock Option | |
| MiNK Therapeutics Inc | Buell S. Jennifer | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 500,000 | 500,000 | - | - | Stock Option | |
| MiNK Therapeutics Inc | Jennifer S. Buell | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2023 | 500,000 | 500,000 | - | - | Stock Option | |
| MiNK Therapeutics Inc | Jennifer S. Buell | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 2.32 per share. | 09 Jan 2023 | 171,990 | 380,715 | - | 2.3 | 399,017 | Common Stock |
| MiNK Therapeutics Inc | Jennifer S. Buell | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2022 | 679,800 | 679,800 | - | - | Stock Option (Right to Buy) |